Merck: Health care overhaul to cost $320M in 2010 – BusinessWeek
Merck, based in Whitehouse Station, N.J., is the maker of asthma and allergy drug Singulair and cholesterol drugs Vytorin and Zetia. It is slated to report its first-quarter results on May 4. Merck shares, which had been trading up Friday before the …
No related posts.
Write a comment: